Tivozanib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 189 publications
Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors
Journal: Aktuelle Urologie
Published: February 05, 2026
Mechanistic insights into Gwt1-substrate interactions and antifungal drug discovery via molecular dynamics and virtual screening.
Journal: Journal of biomolecular structure & dynamics
Published: January 12, 2026
A systematic review comparing sex-specific outcomes of prospective clinical trials and subsequent real-world data focusing on systemic treatment options for renal cell cancer.
Journal: Urologia internationalis
Published: December 03, 2025
Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: November 25, 2025
Vascular endothelial cells and angiogenesis.
Journal: Pharmacological research
Published: October 04, 2025
From Biomarker to Drug Target: Integrating ceRNA Networks and Pharmacogenomics to Reposition C5orf34 in Uterine Corpus Endometrial Cancer Therapy.
Journal: Current medicinal chemistry
Published: September 02, 2025
Buccodental Toxicities Induced by Tyrosine Kinase Inhibitors in Patients Diagnosed with Renal Cell Carcinoma-A Literature Review.
Journal: Dentistry journal
Published: August 11, 2025
Identification and Structural Characterization of Degradation Products of Tivozanib Using LC-Q-TOF-MS/MS and NMR: An In Silico Approach for Degradation and Toxicity Prediction.
Journal: Rapid communications in mass spectrometry : RCM
Published: June 27, 2025
Last Updated: 04/28/2026